Welcome to our dedicated page for VENAU news (Ticker: VENAU), a resource for investors and traders seeking the latest updates and insights on VENAU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VENAU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VENAU's position in the market.
Venus Acquisition Corporation has successfully closed its initial public offering (IPO), raising a total of $46,000,000 from the sale of 4,600,000 units priced at $10.00 each. The IPO units began trading on The Nasdaq Capital Market under the ticker symbol VENAU. Each unit comprises one ordinary share, one right to receive a fraction of an ordinary share, and one warrant exercisable at $11.50. The offering included a full exercise of the underwriters' over-allotment option by an additional 600,000 units.
On February 8, 2021, Venus Acquisition Corporation announced the pricing of its initial public offering (IPO) of 4,000,000 units at $10.00 each. The units, expected to trade on NASDAQ under the ticker symbol 'VENAU' starting February 9, 2021, consist of one ordinary share, a right to receive one-tenth of an ordinary share, and a warrant to acquire half an ordinary share at an exercise price of $11.50. The offering is set to close on February 11, 2021, pending customary closing conditions. Ladenburg Thalmann & Co. Inc. leads the underwriting team.
